Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.
Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.
复制标题
DOI:
10.1158/0008-5472.can-16-1701
复制
发表时间:
2018-06-15
期刊:
影响因子:
11.2
通讯作者:
Sood AK
中科院分区:
文献类型:
--
作者:
Allen JK;Armaiz-Pena GN;Nagaraja AS;Sadaoui NC;Ortiz T;Dood R;Ozcan M;Herder DM;Haemmerle M;Gharpure KM;Rupaimoole R;Previs RA;Wu SY;Pradeep S;Xu X;Han HD;Zand B;Dalton HJ;Taylor M;Hu W;Bottsford-Miller J;Moreno-Smith M;Kang Y;Mangala LS;Rodriguez-Aguayo C;Sehgal V;Spaeth EL;Ram PT;Wong STC;Marini FC;Lopez-Berestein G;Cole SW;Lutgendorf SK;De Biasi M;Sood AK
Mounting clinical and preclinical evidence supports a key role for sustained adrenergic signaling in the tumor microenvironment as a driver of tumor growth and progression. However, the mechanisms by which adrenergic neurotransmitters are delivered to the tumor microenvironment are not well understood. Here we present evidence for a feedforward loop whereby adrenergic signaling leads to increased tumoral innervation. In response to catecholamines, tumor cells produced brain-derived neurotrophic factor (BDNF) in an ADRB3/cAMP/Epac/JNK-dependent manner. Elevated BDNF levels in the tumor microenvironment increased innervation by signaling through host neurotrophic receptor tyrosine kinase 2 (TrkB) receptors. In cancer patients, high tumor nerve counts were significantly associated with increased BDNF and norepinephrine levels and decreased overall survival. Collectively, these data describe a novel pathway for tumor innervation with resultant biological and clinical implications.